EARS - Auris Medical Holding Ltd.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.76M
Enterprise Value 34.7M
Trailing P/E N/A
Forward P/E 1-0.38
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.33
52-Week Change 3-80.98%
S&P500 52-Week Change 321.38%
52 Week High 39.2000
52 Week Low 31.3000
50-Day Moving Average 31.4684
200-Day Moving Average 31.9761

Share Statistics

Avg Vol (3 month) 3149.29k
Avg Vol (10 day) 359.27k
Shares Outstanding 53.27M
Float 2.49M
% Held by Insiders 111.82%
% Held by Institutions 116.10%
Shares Short (Jan 30, 2020) 434.45k
Short Ratio (Jan 30, 2020) 40.2
Short % of Float (Jan 30, 2020) 42.20%
Short % of Shares Outstanding (Jan 30, 2020) 41.04%
Shares Short (prior month Dec 30, 2019) 446.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 30, 2019

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Jun 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-49.77%
Return on Equity (ttm)-380.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-1.3270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.54
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A